(Q47748338)
Statements
1 reference
ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis (English)
1 reference
1 reference
Louis M Havekes
1 reference
Albert K Groen
1 reference
Carlos Vrins
1 reference
Ko Willems van Dijk
1 reference
Patrick C N Rensen
1 reference
Peter J Voshol
1 reference
Hendrik N van der Vliet
1 reference
Robert A F M Chamuleau
1 reference
16 April 2004
1 reference
279
1 reference
27
1 reference
27941-27947
1 reference